Blog
New

Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants

Genetic risk from rare copy number variants and common single-nucleotide polymorphisms may contribute to liability to schizophrenia.

Read More
New

Revised Children’s Anxiety and Depression Scales Reliable Measurement Tool for Adults

RCADS is often used to measure anxiety and depression and researchers assessed its structural validity for adults, given the life span nature of anxiety.

Read More
New

Symptom Improvement Seen With Interpersonal Psychotherapy, Sertraline in Postpartum Women

Investigators examined the efficacy of sertraline and interpersonal psychotherapy vs pill placebo over 12 weeks in woman with postpartum depression.

Read More
New

FDA to Review Lumateperone for Treatment of Schizophrenia

Lumateperone and follow-on compounds are also being evaluated for bipolar depression, behavioral disturbance associated with dementia, sleep disturbances associated with neuropsychiatric disorders, and other neuropsychiatric conditions including major depressive disorder and autism.

Read More
New

Polygenic Risk Scores May Predict Antipsychotic Efficacy in Schizophrenia

The use of a polygenic risk score for schizophrenia can effectively predict an antipsychotic treatment response after a first episode of psychosis.

Read More
New

Can Examining Marginalization Identify Gaps in Medical or Nutritional Care?

Healthcare interventions should assess the multiple layers of a person’s life, rather than simply classifying marginalized groups as vulnerable.

Read More
New

Efficacy, Safety of Long-Term Ketamine Administration Still In Question

Ketamine, originally approved by the FDA in 1970 as an anesthetic, is increasingly being recognized as an option in treatment-resistant depression.

Read More
New

Vulnerability to Psychosocial Disability in Psychosis

Psychosis, or a psychotic episode, is characterized by a distorted perception of reality that is often exacerbated by hallucinations or delusions.

Read More
New

Behavioral Health Screening Advocated for Teens With Epilepsy

Teen patients with epilepsy experience high levels of depressive symptoms, with 13% requiring behavioral health interventions.

Read More
New

KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder

The use of ezogabine, a KCNQ channel opener, may improve depression and anhedonic symptoms in patients with major depressive disorder.

Read More
New

Psychotic Experiences May Predict Future Suicidal Behaviors

Psychotic experiences may be a clinical marker of risk for future suicidal behaviors.

Read More
New

Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults

Future studies need to determine whether improvement in cognition with abstinence is associated with improvement in academic and other functional outcomes.

Read More
New

Effects of Mindfulness Meditation on Mood in Middle-Age, Older Adults

Mindfulness meditation training may reduce negative affect variability in middle-age and older adults.

Read More
New

Psychosocial Intervention Improves Anxiety and Quality of Life in Patients With Psoriasis

A recent review found that existing psychosocial interventions using cognitive-behavioral and mindfulness-based approaches had a small but significant effect on quality of life and anxiety outcomes in patients with psoriasis.

Read More
New

Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety

Investigators conducted a comprehensive literature review to determine whether CBT is the most effective form of psychotherapy for children with anxiety disorders.

Read More
New

Noninvasive Brain Stimulation of Prefrontal Cortex in Trait Anxiety

The role of noninvasive brain stimulation of the prefrontal cortex on amygdala threat reactivity in individuals with trait anxiety was examined.

Read More